Fig. 4From: Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort studyRisks of clinical events of rivaroxaban versus dabigatran treatment in 3 groupsBack to article page